Related Experiment Video
Updated: Apr 27, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Effects of haloperidol on Kv4.3 potassium channels
Hong Joon Lee1, Ki-Wug Sung1, Sang June Hahn2
1Department of Pharmacology, Cell Death and Disease Research Center, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, , Seoul 137-701, Republic of Korea.
Insights
Haloperidol, used for psychosis, affects Kv4.3 potassium channels by accelerating inactivation and causing a concentration-dependent block. This impacts cardiac function, potentially explaining cardiovascular events associated with the drug.
Area of Science:
- Cardiovascular Pharmacology
- Ion Channel Physiology
- Neuropharmacology
Background:
- Haloperidol is a widely used antipsychotic medication.
- Adverse cardiovascular events are a known risk associated with haloperidol treatment.
- Understanding the molecular mechanisms underlying these events is crucial for patient safety.
Purpose of the Study:
- To investigate the direct effects of haloperidol on Kv4.3 potassium currents.
- To elucidate the specific interactions between haloperidol and Kv4.3 channel kinetics.
- To determine the concentration-dependent effects and potential mechanisms of haloperidol-induced channel modulation.
Main Methods:
- Whole-cell patch-clamp technique was employed to record Kv4.3 currents in stably transfected CHO cells.
- Concentration-response relationships were analyzed for haloperidol's effects on current amplitude and kinetics.
- Voltage-dependence of activation and inactivation, as well as recovery from inactivation, were assessed.
Main Results:
- Haloperidol did not significantly inhibit the peak amplitude of Kv4.3 currents.
- Haloperidol accelerated the inactivation and activation decay rates of Kv4.3 in a concentration-dependent manner.
- A concentration-dependent decrease in Kv4.3 current integral (IC50 = 3.6 μM) was observed, alongside a use-dependent block and slowed recovery from inactivation.
Conclusions:
- Haloperidol modulates Kv4.3 channel function by accelerating inactivation and activation kinetics.
- The drug exhibits a concentration-dependent block, affecting both open and closed states of the Kv4.3 channel.
- These findings provide insights into the potential electrophysiological basis for haloperidol's cardiovascular side effects.
Abstract:
Haloperidol is commonly used in clinical practice to treat acute and chronic psychosis, but it also has been associated with adverse cardiovascular events. We investigated the effects of haloperidol on Kv4.3 currents stably expressed in CHO cells using a whole-cell patch-clamp technique. Haloperidol did not significantly inhibit the peak amplitude of Kv4.3, but accelerated the decay rate of inactivation of Kv4.3 in a concentration-dependent manner. Thus, the effects of haloperidol on Kv4.3 were estimated from the integral of the Kv4.3 currents during the depolarization pulse. The Kv4.3 was decreased by haloperidol in a concentration-dependent manner with an IC50 value of 3.6 μM. Haloperidol accelerated the decay rate of Kv4.3 inactivation and activation kinetics in a concentration-dependent manner, thereby decreasing the time-to-peak. Haloperidol shifted the voltage dependence of the steady-state activation and inactivation of Kv4.3 in a hyperpolarizing direction. Haloperidol also caused an acceleration of the closed-state inactivation of Kv4.3. Haloperidol produced a use-dependent block of Kv4.3, which was accompanied by a slowing of recovery from the inactivation of Kv4.3. These results suggest that haloperidol blocks Kv4.3 by both interacting with the open state of Kv4.3 channels during depolarization and accelerating the closed-state inactivation at subthreshold membrane potentials.
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

